DAPHIN NAHIKIRIZA
ID:
|
'SAVINGS AND CREDIT COOPERATIVE SOCIETIES AND POVERTY REDUCTION AMONG THE SACCO MEMBERS IN GREATER BUSHENYI, UGANDA'
REFNo: SS1853ES
1. To establish the influence of Sacco financial services on poverty reduction among the Sacco members in Greater Bushenyi
2. To examine the influence of Sacco non-financial services on poverty reduction among the Sacco members in Greater Bushenyi.
3. To establish the mediating effect of government policies on the relationship between Sacco services and poverty reduction among the Sacco members in Greater Bushenyi.
|
Uganda |
2023-07-19 11:03:41 |
2026-07-19 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Michael Byamukama
ID:
|
Mathematical Models for Co-infection Dynamics of HIV/AIDS and Pneumonia
REFNo: NS570ES
To formulate and analyse a stochastic mathematical model that incorporates treatment against pneumonia and antiretroviral therapatic effect in indiviuals coinfected with HIV/AIDS and pneumonia.,To derive and analyse an optimal control policy of various intervention measures of HIV/AIDS and pneumonia co-infection.,To determine the combined effect of vaccination and treatment against pneumonia and antiretroviral therapatic effect against HIV/AIDS in the transmission dynamics of HIV/AIDS and pneumonia co-infection.,To formulate and analyze a deterministic mathematical model that incorporates treatment of pneumonia and antiretroviral therapatic effect in indiviuals coinfected with pneumonia and HIV/AIDS.,To develop, analyze and compare mathematical models for the transmission dynamics of HIV/AIDS and pneumonia co-infection.,
|
Uganda |
2023-07-18 8:33:15 |
2026-07-18 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
Lazaaro Mujumbusi
ID: UNCST-2023-R007470
|
Developing a contextualized Health Education program to reduce persistent Schistosomiasis transmission in Ugandan rural fishing communities.
REFNo: SS1819ES
Main Objective
1. To develop, pilot, and evaluate a contextualized participatory community schistosomiasis health education program.
Specific Objectives
1. To develop a set of education interventions and roll them out.
2. To increase awareness about Schistosomiasis and how it affects the internal organs.
3. To explore the views and opinions of various stakeholders about suggested health education programs, acceptability, feasibility and outcome of the health education program.
4. To evaluate the feasibility and acceptability and outcome of the health education programs.
|
Uganda |
2023-07-14 9:57:34 |
2026-07-14 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Joyce Nalunga
ID:
|
GENDER BASED VIOLENCE, PUBLIC HEALTH CONSEQUENCES, AND SOCIETAL IMPACT ON REFUGEES IN UGANDA. A CASE OF BIDIBIDI CAMP, YUMBE DISTRICT, WEST NILE UGANDA
REFNo: SS1816ES
To main objective of the study is to investigate the Impact of Gender based Violence 0n society among refugees in Uganda so as to develop an inclusive model for improvement in refugee settlements
The specific objectives are as follows:
i) To analyse the influence of gender based violence on public health consequences among refugees in BidiBidi camp in Yumbe, District, West Nile Uganda
ii) To assess the relationship between public consequences and societal impact among refugees in BidiBidi camp in Yumbe, District, West Nile Uganda
iii) To examine the fit between gender based violence and societal impact among refugees in Yumbe, District, West Nile Uganda
iv) To investigate the mediating effect of gender based violence on the fit of publi health consequences and societal impact in Yumbe, District, West Nile Uganda
|
Uganda |
2023-07-14 9:52:07 |
2026-07-14 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Grace Mirembe
ID: UNCST-2022-R008850
|
RV 591 entitled “A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of an Ad26.Mos4.HIV and CH505 TF chTrimer (Env) Combination to Mimic Acute HIV Viral Replication Kinetics in Healthy Adults”
REFNo: HS2891ES
To assess the safety, reactogenicity and tolerability of two vaccination regimens: rapid dose-escalation of CH505 TF chTrimer+ALFQ and Ad26.Mos4.HIV or co-administration of CH505 TF chTrimer+ALFQ and Ad26.Mos4.HIV
|
Uganda |
2023-07-14 9:49:16 |
2026-07-14 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Alma Ionescu Bianca
ID:
|
An ethnographic study of mental health activism in Uganda
REFNo: SS1741ES
General objective:
To understand how mental health advocacy and activism function as drivers of social change in Uganda, in order to understand and envision grassroots alternatives to create better environments for mental health
Specific objectives:
i. To explore drivers and possibilities of social change for health equity through mental health activism and advocacy in Uganda.
ii. To produce a literature review identifying the mechanisms and strategies of mental health activism and advocacy in LMIC.
iii. To explore the interconnectedness an
|
Romania |
2023-07-14 9:43:55 |
2026-07-14 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Nadja Peter
ID:
|
Reactions to Global Inequality
REFNo: SS1710ES
incorporate perspectives from different parts of the world,explore causal attributions people give for global inequality,
|
Germany |
2023-07-14 9:42:00 |
2026-07-14 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Joy Gumikiriza- Onoria Louise
ID:
|
Development of a Caregiver Centered Psychotherapy (CCPT) in addressing patient care for older persons with Alzheimer’s Disease and Related Dementias (ADRD) in Uganda.
REFNo: HS2909ES
1. To explore ways in which older people in the community of Wakiso district conceptualize ADRD and what informs their opinions. 2. To assess caregiver distress, non-professional techniques of patient care, quality of life and the associated factors among family caregivers of persons with ADRD in Wakiso district.To adapt and pre-test the WHO-iSupport for family caregivers of persons with ADRD in Wakiso, Uganda4. To determine the effectiveness of A-iSupport in the alleviation of distress among family caregivers of persons with ADRD in Wakiso, Uganda
|
Uganda |
2023-07-14 9:40:03 |
2026-07-14 |
Medical and Health Sciences |
Clinical Trial |
Degree Award |
|
Turyahebwa Claire
ID:
|
MECS East Africa Battery-eCooking Field Trial, Uganda
REFNo: SIR105ES
The aims of this study are to examine the technical performance in real-life use and user experience of battery-augmented electric cooking equipment. Specifically, we are aiming to answer the following questions: - How will this technology perform in a real life situation, with real cooks? What technical changes are needed in the future to make this product more attractive to everyday cooks? - How will cooks respond to using the technology? How do they adopt it over time? In addition, we will be studying the following: - Are the devices compatible with traditional cooking practices? Could they encourage households to move towards clean energy stack? How do everyday cooks use the devices? What are their preferences for features of the devices? How can we make the devices more desirable and sustainable? What are gender implications of using the device? - What is the commercial viability of e-cooking (socially, technically, financially viable)? - How do the batteries perform in a real life setting? How much wear does the battery undergo? What are potential impacts on the grid? When, how, and to what extent is the battery power used? - What are health impacts of using the device?
|
Uganda |
2023-07-14 9:36:50 |
2026-07-14 |
Engineering and Technology |
Non-Clinical Trial |
Non-degree Award |
|
Nixon Niyonzima
ID: UNCST-2020-R014577
|
A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO-TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER (HeredERA)
REFNo: HS2968ES
To identify and/or evaluate biomarkers that are predictive of response to Phesgo and giredestrant (i.e., predictive biomarkers), are early surrogates of efficacy, are associated with progression to a more severe disease state (i.e., prognostic biomarkers), are associated with acquired resistance to Phesgo and giredestrant, are associated with susceptibility to developing adverse events or can lead to improved adverse event monitoring or investigation (i.e., safety biomarkers), can provide evidence of Phesgo and giredestrant activity (i.e., pharmacodynamic biomarkers), or can increase the knowledge and understanding of disease biology and drug safety,To evaluate potential effects of ADAs,To evaluate the immune response to pertuzumab, trastuzumab, and rHuPH20,To evaluate the potential relationships between Phesgo and giredestrant exposure and the safety, efficacy, immunogenicity, or biomarker endpoints.,To characterize the giredestrant, pertuzumab, and trastuzumab PK profile when given in combination,To evaluate the safety of Phesgo plus giredestrant compared with Phesgo from the participant's perspective,To evaluate health utility of participants treated with Phesgo plus giredestrant compared with Phesgo to generate utility scores for use in economic models,To evaluate effects of Phesgo plus giredestrant compared with Phesgo on work productivity and activity,To evaluate the safety of Phesgo plus giredestrant compared with Phesgo,To evaluate the efficacy of Phesgo plus giredestrant compared with Phesgo,
|
Uganda |
2023-07-14 12:43:26 |
2026-07-14 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|